Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1413754/000107878219000201/f10k123118_10k.htm
SEC Filings
MRZM Annual Reports
MRZM Quarterly Reports
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report November 2019
MRZM Corporate News
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales February 2023
Bylaw Change
Financial Exhibit
New Agreement
Security Holders Change January 2023
Bylaw Change
Financial Exhibit
Security Holders Change January 2023
Vote of Security Holders December 2022
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales August 2022
Bylaw Change
Financial Exhibit
Security Holders Change August 2022
Event for Officers May 2022
Event for Officers April 2022
Event for Officers
Financial Exhibit
New Agreement February 2022
Financial Exhibit
Other Events January 2022
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales
New Agreement
New Financial Obligation
Unregistered Sales
February 2023
Bylaw Change
Financial Exhibit
New Agreement
Security Holders Change
Financial Exhibit
New Agreement
Security Holders Change
January 2023
Bylaw Change
Financial Exhibit
Security Holders Change
Financial Exhibit
Security Holders Change
January 2023
Vote of Security Holders
December 2022
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales
New Agreement
New Financial Obligation
Unregistered Sales
August 2022
Bylaw Change
Financial Exhibit
Security Holders Change
Financial Exhibit
Security Holders Change
August 2022
Event for Officers
May 2022
Event for Officers
April 2022
Event for Officers
Financial Exhibit
New Agreement
Financial Exhibit
New Agreement
February 2022
Financial Exhibit
Other Events
Other Events
January 2022
MRZM Registration of Securities
Last10K.com | 10-K Annual Report Tue Mar 05 2019
Document and Entity Information - USD ($) | 12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2018 | Mar. 06, 2019 | Jun. 30, 2018 | |
| Details | |||
| Registrant Name | MARIZYME INC | ||
| Registrant CIK | 0001413754 | ||
| SEC Form | 10-K | ||
| Period End date | Dec. 31, 2018 | ||
| Fiscal Year End | --12-31 | ||
| Trading Symbol | marz | ||
| Tax Identification Number (TIN) | 825464863 | ||
| Number of common stock shares outstanding | 19,740,302 | ||
| Public Float | $ 1,277,175 | ||
| Filer Category | Non-accelerated Filer | ||
| Current with reporting | Yes | ||
| Voluntary filer | No | ||
| Well-known Seasoned Issuer | No | ||
| Shell Company | false | ||
| Small Business | true | ||
| Emerging Growth Company | false | ||
| Amendment Flag | false | ||
| Document Fiscal Year Focus | 2018 | ||
| Document Fiscal Period Focus | FY | ||
| Entity File Number | 000-53223 | ||
| Entity Incorporation, State Country Name | Nevada | ||
| Entity Address, Address Line One | 2950 E. Harmony Rd, Suite 255 | ||
| Entity Address, City or Town | Fort Collins | ||
| Entity Address, State or Province | CO | ||
| Entity Address, Postal Zip Code | 80528 | ||
| Entity Address, Address Description | Address of principal executive offices | ||
| City Area Code | 925 | ||
| Local Phone Number | 400-3123 | ||
| Phone Fax Number Description | Issuer’s telephone number | ||
| Share Price | $ 0.06 |
View differences made from one year to another to evaluate Marizyme Inc's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Marizyme Inc.
Assess how Marizyme Inc's management team is paid from their Annual Proxy
Marizyme Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Document And Entity Information
Balance Sheets
Balance Sheets - Parenthetical
Statement Of Changes In Stockholders' Equity
Statements Of Cash Flows
Statements Of Operations
Note 1 Company And Background
Note 1 Company And Background (Details)
Note 10 Reclassification
Note 2 Accounting Policies
Note 2 Accounting Policies: Assets And Liabilities Held-For-Sale (Policies)
Note 2 Accounting Policies: Assumptions And Estimates (Policies)
Note 2 Accounting Policies: Cash And Cash Equivalents (Policies)
Note 2 Accounting Policies: Comprehensive Income (Loss) (Policies)
Note 2 Accounting Policies: Currency Risk (Policies)
Note 2 Accounting Policies: Deferred Taxes (Policies)
Note 2 Accounting Policies: Fair Value Measurements (Policies)
Note 2 Accounting Policies: Financial Instruments (Policies)
Note 2 Accounting Policies: Foreign Currency Balances And Transactions (Policies)
Note 2 Accounting Policies: Intangible Assets (Policies)
Note 2 Accounting Policies: Net Income Per Common Share (Policies)
Note 2 Accounting Policies: Other Provisions (Policies)
Note 2 Accounting Policies: Recent Accounting Pronouncements (Policies)
Note 2 Accounting Policies: Revenue Recognition (Policies)
Note 2 Accounting Policies: Segment Reporting (Policies)
Note 3 Assets And Liabilities Held For Sale
Note 3 Assets And Liabilities Held For Sale (Details)
Note 4 Intangible Assets
Note 5 Convertible Note Payable
Note 5 Convertible Note Payable (Details)
Note 6 Capital Stock
Note 6 Capital Stock (Details)
Note 6 Capital Stock: Options And Warrants (Details)
Note 7 Commitments
Note 8 Legal Proceedings
Note 9 Income Taxes
Note 9 Income Taxes: Schedule Of Deferred Tax Assets And Liabilities (Details)
Note 9 Income Taxes: Schedule Of Deferred Tax Assets And Liabilities (Tables)
Note 9 Income Taxes: Schedule Of Effective Income Tax Rate Reconciliation (Details)
Note 9 Income Taxes: Schedule Of Effective Income Tax Rate Reconciliation (Tables)
Material Contracts, Statements, Certifications & more
Marizyme Inc provided additional information to their SEC Filing as exhibits
Ticker: MRZM
CIK: 1413754
Form Type: 10-K Annual Report
Accession Number: 0001078782-19-000201
Submitted to the SEC: Tue Mar 05 2019 1:34:08 PM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Monday, December 31, 2018
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/mrzm/0001078782-19-000201.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...